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In addition to being at risk of physical abnormalities, such
as heart defects and cleft palate, people with the chromo-
some 22q11 deletion syndrome can also have learning dis-
abilities, autism, and delays in reaching motor milestones,
and they are at increased risk of psychiatric illnesses, par-
ticularly schizophrenia. A well-delineated and recurrent
microdeletion is the main culprit, but we haven’t been
able to translate the identity of the missing genes in this
segment to a meaningful understanding of the develop-
ment of this syndrome. In a mouse model of 22q11 dele-
tion syndrome, Stark et al. found that impaired microRNA
(miRNA) biogenesis underlies, at least partially, the behav-
ioral and neuronal deﬁcits associated with this microdele-
tion. They found several miRNA-containing transcripts
among the genes that exhibited altered expression in the
brains of mice with the deletion. Within the deletion is
Dgcr8, a gene that encodes a part of the complex that pro-
cesses primary forms of miRNAs to their mature counter-
parts. As expected if deletion of this gene limits processing
of primary forms of the miRNAs, there is increased expres-
sion of certain primary miRNAs, and a corresponding
downregulation of a smaller set of mature miRNAs, in
the brains of mice with the microdeletion. The defects in
miRNA biogenesis were attributable to loss of Dgcr8 be-
cause they were recapitulated in mice with a speciﬁc het-
erozygous deletion of this gene. Further, the microdeletion
andDgcr8þ/mousemodels share some cognitive and neu-
ronal deﬁcits. Although abnormal miRNA processing ap-
pears to contribute to the phenotype of 22q11 deletion
syndrome, Dgcr8 deﬁciency does not fully account for all
features of the syndrome.
Stark et al. (2008). Nat. Genet. Published online May 11,
2008. 10.1038/ng.138.
Neural Crest Cells on the Move
Among the many features of Bardet-Biedl syndrome (BBS)
are subtle craniofacial defects that have proven difﬁcult to
describe and characterize. That is, until computers got in-
volved. Tobin et al. used three-dimensional dense surface
modeling to analyze the faces of people with BBS com-
pared to controls, and they have been able to deﬁne quan-
titatively the differences in facial structure. The changesThe Amthey found are in the midfacial region and include nasal
bridge hypoplasia and nasal shortening, midfacial ﬂatten-
ing, and retrognathia. In addition to providing an objec-
tive way to recognize the facial features of BBS, this work
opened a window in the search for similar changes in ani-
mal models. Indeed, parallel craniofacial features are seen
in mouse models of BBS and in zebraﬁsh embryos treated
with morpholinos to the bbs genes. Detailed observations
of the zebraﬁsh embryos indicate that the craniofacial de-
fects result from an inhibition of neural crest cell migra-
tion, and this inhibition can be mimicked through the in-
duction of noncanonical Wnt signaling. An insensitivity
to sonic hedgehog signaling when one of the bbs proteins
is deﬁcient contributes further to the craniofacial abnor-
malities. Another feature of BBS is Hirschsprung disease,
the absence of enervation to a portion of the gut. This is
another defect that can be attributed to neural crest cell
migration; in zebraﬁsh treated with morpholinos to bbs8,
neurons fail tomigrate properly into the hindgut.Whether
and how cellular migration defects contribute to the other
features of BBS remains to be elucidated.
Tobin et al. (2008). PNAS 105, 6714–6719. 0.1073/
pnas.0707057105.
The Ins and Outs of the Nuclear Lamina
We know that speciﬁc regions of chromosomes are located
near the nuclear lamina, but the complete identity of these
regions—and how they contribute to spatial organization
in the nucleus—isn’t clear. Guelen et al. used the new
DamID technique to map areas of the human genome
that are associated with lamin B1. In this procedure, a fu-
sion protein containing lamin B1 and the DNA adenine
methyltransferase was introduced into ﬁbroblasts. When
lamin B1 interacts with DNA, adenines in the vicinity are
methylated, and these regions are ampliﬁed by methyla-
tion-speciﬁc PCR and identiﬁed on microarrays. Over
1000 lamina-associated domains were identiﬁed, and there
is a striking pattern of chromosomal domains that exhibit
a high level of lamina association alternated with those
that exhibit a very low level of association. Regions of
the genome that are strongly associated with the lamina
have several notable features that suggest that they repre-
sent inactive chromatin. These include a mean gene den-
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a reduction in gene expression within the domains, and an
increased density of outwardly directed promoters just out-
side the domains. Also tending to ﬂank the lamina-associ-
ated domains are CpG islands and binding motifs for the
insulator protein CTCF, features that could help to delin-
eate the lamina-associated regions. This map puts us on
the road to understanding the architecture of the genome
as it exists within the interphase nucleus.
Guelen et al. (2008) Nature. Published online May 7, 2008.
10/1038/nature06947.
A Mouse Model of Preeclampsia
Preeclampsia in pregnancy is marked by hypertension and
the presence of protein in themother’s urine. If it is allowed
to progress, seizures, coma, and even death of the mother
can result. Preeclampsia also has implications for the
baby; it can lead to restricted blood ﬂow to the placenta,
causing fetal-growth restriction and preterm birth. Al-
though preeclampsia is a well-studied phenomenon, we
don’t fully understand the factors that trigger it in some
women, and the key treatment is to deliver the baby. Kana-
saki et al. ﬁnd that mice that lack catechol-O-methyltrans-
ferase (COMT) expression have a phenotype that mimics
preeclampsia, and this model has allowed them to identify
additional contributors to this process. The effect of COMT
deﬁciency is due to a lack of production of 2-methoxyestra-
diol (2-ME), which is a product of COMTactivity and ame-
tabolite of estradiol that is elevated during normal preg-
nancy. Decreased 2-ME induces expression of HIF1a and
sFLT-1, two proteins thought to contribute to the develop-
ment of preeclampsia. Not only does the phenotype of
theComt/micemimic that of womenwith preeclampsia,
but circulating 2-ME levels inwomenwith preeclampsia are
lower than those in other pregnantwomen, suggesting that1230 The American Journal of Human Genetics 82, 1229–1230, Junthe same pathologic process might occur in humans. The
lower levels of 2-ME in preeclamptic women also suggest
it might be possible to develop amuch-needed screen or di-
agnostic test for preeclampsia on the basis of 2-MEmeasure-
ments. Because administration of 2-ME to Comt/ mice
prevents the preeclampsia-like phenotype in this model,
this pathway might yield clues as to how we might better
treat preeclampsia.
Kanasaki et al. (2008). Nature. Published online May 11,
2008. 10.1038/nature06951.
A New Means to the End
Many human genes utilizemore than one polyadenylation
site, a phenomenon that generates transcriptional diver-
sity. We know that site selection can be governed in a tis-
sue-speciﬁc manner via changes in the concentration of
RNA processing factors, but there are almost certainly
other mechanisms by which the polyA site is determined.
One of these other factors turns out to be genetic imprint-
ing. Wood et al. report a novel imprinted domain on
mouse chromosome 2 that contains two genes, H13 and
Mcts2. Mcts2 is located within an intron of H13, and its
promoter has a CpG island that is methylated in the female
germline. This methylation inﬂuences the utilization of
polyA sites for H13, with preferential use of polyA sites
downstream of the differentially methylated region onma-
ternal alleles. These preferences are abolished in embryos
lackingmaternally derivedmethylation imprints as a result
of a Dnmt3l deﬁciency in the mother. Although we may
not understand the mechanism, genetic imprinting is
one way by which polA site selection can be controlled,
even in early embryos.
Wood et al. (2008) Genes Dev. 22, 1141–1146. 10.1101/
gad.473408.e 2008
